RecruitingNot ApplicableNCT05356182

A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies


Sponsor

State University of New York at Buffalo

Enrollment

30 participants

Start Date

May 4, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The main idea of this study is that a low protein diet may alter the environment surrounding the tumor, enhancing the body's immune response leading to greater anticancer effects of treatment. This study intends to use a low-protein diet as a tool to enhance the immune response generated by immune check point inhibitor treatments.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Diet for people with integrative oncology, medical nutrition therapy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDiet

Control diet consisting of 20% protein, intervention diet consisting of 10% protein


Locations(1)

University at Buffalo / Great Lakes Cancer Care

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05356182


Related Trials